T2 Biosystems Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.25 |
Market Cap |
$74.49 M |
Shares Outstanding |
44.34 M |
Public Float |
35.13 M |
Address |
101 Hartwell Avenue Lexington Massachusetts 02421 United States |
Employees | - |
Website | http://www.t2biosystems.com |
Updated | 07/08/2019 |
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J. |